Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
Flavio M Ceci1, Mauro Ceccanti2, Carla Petrella3
1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Insights
Moderate alcohol consumption may lower atherosclerotic neuro-cardiovascular disease (ACVD) risk by increasing high-density lipoprotein (HDL) cholesterol. However, heavy drinking and genetic factors like apolipoprotein E4 can increase ACVD risk, meaning moderate drinking benefits aren't universal.
Area of Science:
- Cardiovascular Science
- Genetics
- Nutritional Science
Background:
- Lipoprotein disorders are key risk factors for atherosclerotic neuro-cardiovascular disease (ACVD).
- Lifestyle factors, particularly alcohol consumption, significantly influence ACVD risk.
- Moderate alcohol intake is associated with higher high-density lipoprotein (HDL) cholesterol and lower ACVD risk compared to abstinence.
Purpose of the Study:
- To investigate the complex relationship between alcohol consumption, lipid profiles, and ACVD risk.
- To explore the influence of genetic polymorphisms on alcohol's impact on ACVD.
- To determine if the protective effects of moderate drinking extend to all individuals.
Main Methods:
- Literature review of studies examining alcohol intake, lipid serum profiles, and ACVD.
- Analysis of genetic polymorphisms (Apolipoprotein E, Interleukin-6, CETP) in relation to alcohol consumption and ACVD risk.
- Examination of ethanol's effects on lipid profiles and endothelial function.
Main Results:
- Heavy alcohol consumption is linked to increased ACVD risk and adverse changes in lipid profiles.
- Genetic factors, including Apolipoprotein E4, IL-6-174, and CETP TaqIB polymorphisms, may exacerbate ACVD risk in heavy drinkers.
- The cardioprotective association of moderate drinking, mediated by HDL cholesterol, is not universally applicable due to genetic variations.
Conclusions:
- While moderate alcohol intake may offer some cardiovascular protection, this benefit is not universal.
- Genetic predispositions can modify the relationship between alcohol consumption and ACVD risk.
- Heavy drinking poses a significant risk for ACVD, potentially amplified by specific genetic profiles.
Abstract:
Lipoprotein disorders are a major risk factor for atherosclerotic neuro-cardiovascular disease (ACVD) and are heavily influenced by lifestyle, including alcohol drinking. Moderate drinkers have a lower ACVD risk than abstainers due to their higher levels of high-density lipoprotein (HDL) cholesterol, an important protective factor against ACVD. On the contrary, heavy drinking increases ACVD risk. According to an extensive literature body, ethanol intoxication modifies lipid serum profile and induces endothelial dysfunction. Single nucleotide polymorphisms may influence the relationship between alcohol drinking, HDL cholesterol level, and atherosclerotic risk. The risk of ACVD in heavy drinkers seems enhanced in patients with apolipoprotein E4 allele, interleukin- 6-174 polymorphism, and cholesteryl ester transfer protein TaqIB polymorphism. Apolipoprotein E4 is a known risk factor for ACVD, while apolipoprotein E2 has mixed effects. Therefore, even if a "protective role" may be attributed to moderate drinking, this effect cannot be extended to everyone.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Atherosclerosis I: Introduction
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
